In This Article:
- By insider
Chairman, President & CEO of Merck & Co Inc (MRK) Kenneth C Frazier sold 192,736 shares of MRK on 03/20/2019 at an average price of $82.05 a share. The total sale was $15.8 million.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co Inc has a market cap of $211.87 billion; its shares were traded at around $82.08 with a P/E ratio of 35.38 and P/S ratio of 5.21. The dividend yield of Merck & Co Inc stocks is 2.51%. Merck & Co Inc had annual average EBITDA growth of 0.20% over the past ten years.
-
Warning! GuruFocus has detected 3 Warning Signs with ATNX. Click here to check it out.
-
The intrinsic value of MRK
CEO Recent Trades:
-
Chairman, President & CEO Kenneth C Frazier sold 192,736 shares of MRK stock on 03/20/2019 at the average price of $82.05. The price of the stock has increased by 0.04% since.
-
Chairman, President & CEO Kenneth C Frazier sold 18,725 shares of MRK stock on 03/13/2019 at the average price of $82. The price of the stock has increased by 0.1% since.
-
Chairman, President & CEO Kenneth C Frazier sold 20,105 shares of MRK stock on 03/05/2019 at the average price of $82. The price of the stock has increased by 0.1% since.
-
Chairman, President & CEO Kenneth C Frazier sold 95,953 shares of MRK stock on 02/22/2019 at the average price of $80.01. The price of the stock has increased by 2.59% since.
-
Chairman, President & CEO Kenneth C Frazier sold 135,613 shares of MRK stock on 02/19/2019 at the average price of $80.03. The price of the stock has increased by 2.56% since.
For the complete insider trading history of MRK, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 3 Warning Signs with ATNX. Click here to check it out.
-
The intrinsic value of MRK